2nd Quarter - Amendment

HELIX, INC. for HELIX, INC.

Firm
Client
Income
—
Expenses
$110,000
Expense method
A: Lobbying Disclosure Act definitions

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
2nd Quarter - Report Jul 8, 2022 $36,520 Replaced
2nd Quarter - Amendment (this page) Aug 3, 2023 $110,000 Yes

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Genomic research and testing, pandemic preparedness, viral surveillance, regulation of Lab Developed Tests in VALID ACT USH 4128 and PREVENT Act. Also US H 791 COVID-19 Variant Data Tracking, USH 6589 Clinical Trial Diversity. USH 7667 Rx Drug and Device User Fees, US S 236 COVID-19 Variants Program.

LobbyistCovered position, as disclosed
KELLI ARTHUR HYKES —

Contacted: White House Office; HOUSE OF REPRESENTATIVES; Centers For Disease Control & Prevention (CDC); SENATE

Medical/Disease Research/Clinical Labs MED

genomic research and testing, COVID-19 testing,research, and respiratory pathogen sequencing and surveillance, Lab Developed Tests USH 4128

LobbyistCovered position, as disclosed
KELLI ARTHUR HYKES New —

Contacted: HOUSE OF REPRESENTATIVES; Centers For Disease Control & Prevention (CDC); SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.